Venture-Med Angel Investment Group is a membership organization of accredited investors dedicated to funding and mentoring new healthcare start ups. We focus on medical devices, healthcare IT, and mobile health platforms that will enhance patient safety and outcomes. Apply for Membership.
We provide unparalleled access, mentorship and support to early-stage companies that have IP, a strong team, domain expertise and vision. Learn more about our Screening and Evaluation Process.
We are excited to bring you the best experience in previewing innovation in healthcare. Each company is screened for maturity and valued on a 20 point multi-factor scale. Please register to join us as a guest at our next event.
View Upcoming Events.
We are pleased to announce our new funding platform, MedXForward. Read more.
NEW YORK (Reuters) - A federal judge ruled on Monday in favor of two tobacco companies that challenged a 2011 U.S. Food and Drug Administration committee report on menthol cigarettes, finding three of the panel's members had conflicts of interests. […]
LONDON (Reuters) - A group of seven leading drugmakers has agreed to share an array of neglected experimental medicines with British academic researchers in the latest example of the deepening ties between industry and external scientists. […]
NEW YORK (Reuters) - An upstart U.S. food technology company has developed a unique fermentation process using mushrooms to reduce bitterness in cocoa beans that it believes will cut sugar content in chocolate candy. […]
CHICAGO (Reuters) - The U.S. Centers for Disease Control and Prevention "may never know" how a fairly harmless form of bird flu was cross-contaminated with a dangerous bird flu strain before it was sent to a laboratory outside of the CDC, an agency spokesman said on Monday. […]
Medtech titan Boston Scientific lands FDA approval for its Rebel bare-metal stent, made of the company's proprietary platinum chromium alloy. Massachusetts medical device giant Boston Scientific (NYSE:BSX) today announced FDA approval for the latest in its line of coronary stents, the Rebel bare-metal stent. Boston ScientificNews Well, Regulatory/Cleara […]
Wall Street rallies as dental laser maker Biolase raises $12 million through a private placement round, even as the company deals with an ongoing civil war involving ousted CEO Federico Pignatelli. California-based Biolase (NSDQ:BIOL) announced today that it secured $12 million in a private placement funding round, even as the company weathers the internal t […]
A new Federal Circuit Court ruling means Align Technology can move forward with a patent infringement case against rival ClearCorrect. Dental devices maker Align Technology (NSDQ:ALGN) touted a Federal Circuit Court ruling issued this month, calling it a "total win for Align." Align Technology Inc., ClearCorrect, OrthoClearLegal News, News Well, De […]
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry. MassDevice.comNews Well, Plus 3read […]
German surgeons are the world's 1st to use Medrobotics' Flex surgical robot to remove cancerous lesions, launching the company's postmarket clinical trial. Medtech maker Medrobotics celebrated the world's 1st cancer surgeries performed with its Flex surgical robot in a pair of procedures conducted at a hospital in Germany. MedroboticsNews […]